Pharmacology News

PHILADELPHIA — Black patients are highly likely to benefit from prescription of SGLT2 inhibitors for HF, but they are less commonly prescribed them compared with other patients, according to a speaker.

In patients with CV risks, there was a correlation between acetaminophen use and elevated systolic BP, according to a meta-analysis in the European Journal of Preventive Cardiology.

Genetic inhibition of HMG-CoA reductase, a state that mimics long-term statin use, was associated with greater risk for developing cataract compared with individuals without genetic inhibition, researchers reported.

There are seven different anti-obesity medications that are approved in the United States and a number of others that are used off label, most commonly metformin, according to Jennifer C. Seger, MD, FOMA, ABFM, ABOM.

Telemedicine offers the promise of increased efficiency during patient care, but in-person evaluations and relationships are too valuable to completely disregard, according to a debate session at EULAR 2022 Congress.

Roughly seven out of 10 primary care clinicians would inappropriately prescribe antibiotic treatment for asymptomatic bacteriuria, even for patients without risk factors, according to researchers.

The National Lipid Association updated its scientific statement on statin intolerance with a revised definition of statin intolerance and new guidance on how to manage patients with true or partial statin intolerance.

In a cohort of more than 400,000 patients at high risk for CVD requiring primary prevention, less than half were taking appropriately dosed statins and less than 10% were taking nonstatin lipid-lowering therapies, researchers reported.

When treating a patient with multiple diagnoses, it can be difficult to know which to address first.

For patients with type 2 diabetes, first-line SGLT2 inhibitors might be better than metformin when it comes to their cardiovascular health, according to results of a population-based cohort study.